None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Over weight and obese adults without diabetes or any complications Participants willing to take part in the study after providing informed consent
Exclusion criteria
Exclusion criteria: 1.Pregnant or lactating women 2.Participants with diabetes 3.Participants under treatment for dyslipidemia, hypertension or thyroid disorders 4.Those following any weight loss regimen 5.Participants who have any plans of relocating in next 1 year.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insulin resistance(HOMA-IR) Beta cell dysfunction (DIo) Timepoint: Baseline and end of 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting blood glucose HbA1c Lipid profile Selected Inflammatory markers â??adiponectin and interleukin (IL6) Plasma fatty acids (as %)-as marker of complianceTimepoint: Baseline and end of 3 months | — |
Countries
India
Contacts
Madras Diabetes Research Foundation